Antianginal medications and diagnostic accuracy of myocardial perfusion imaging

Journal of Nuclear Cardiology

Volumn 10, Issue 4, 2003, Pages 433-435

  Sabharwal, Nikant Kumar ^a   Lahiri, Avijit ^a  

^a NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE; AMLODIPINE; ANTIANGINA PECTORIS AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIPYRIDAMOLE; DOBUTAMINE; GLYCERYL TRINITRATE; METOPROLOL; NICORANDIL; NITRATE; POTASSIUM CHANNEL STIMULATING AGENT; RANOLAZINE; VASODILATOR AGENT; VERAPAMIL;

ARTICLE; ATHEROSCLEROSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; DIAGNOSTIC ACCURACY; DRUG EFFECT; DRUG HALF LIFE; DRUG WITHDRAWAL; EXERCISE TEST; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART RATE; HUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; VASODILATATION;

EID: 0041385620     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1071-3581(03)00531-2     Document Type: Editorial

References (29)

1. Brown KA, Rowen M. Impact of antianginal medications, peak heart rate and stress level on the prognostic value of a normal exercise myocardial perfusion imaging study. J Nucl Med 1993; 34:1467-71.
2. Sharir T, Rabinowitz B, Livschitz S, et al. Underestimation of extent and severity of coronary artery disease by dipyridamole stress thallium-201 single-photon emission computed tomographic myocardial perfusion imaging in patients taking antianginal drugs. J Am Coll Cardiol 1998;31:1540-6.
3. Bottcher M, Refsgaard J, Madsen MM, et al. Effect of antianginal medication on resting myocardial perfusion and pharmacologically induced hyperemia. J Nucl Cardiol 2003;10:344-51
4. Jain D, Dasgupta P, Hughes LO, Lahiri A, Raftery EB. Ranolazine (RS-43285): a preliminary study of a new anti-anginal agent with selective effect on ischaemic myocardium. Eur J Clin Pharmacol 1990;38:111-4.
5. Subramanian VB, Lahiri A, Paramasivan R, Raftery EB. Verapamil in chronic stable angina. A controlled study with computerized multistage treadmill exercise. Lancet 1980;1:841-4.
6. Reichek N, Sutton MS. Long-acting nitroglycerin for angina, 1982: old dog, new tricks. Ann Intern Med 1982;97:774-6.
7. Fallen EL, Nahmias C, Scheffel A, et al. Redistribution of myocardial blood flow with topical nitroglycerin in patients with coronary artery disease. Circulation 1995;91:1381-8.
8. Thadani U, Parker JO. Influence of glyceryl trinitrate during supine and upright exercise in patients with angina pectoris. Br Heart J 1978;40:1229-36.
9. Thadani U, Hamilton SF, Olson E, et al. Transdermal nitroglycerin patches in angina pectoris. Dose titration, duration of effect, and rapid tolerance. Ann Intern Med 1986;105:485-92.
10. Rodrigues EA, Lahiri A, Hughes LO, et al. Antianginal efficacy of carvedilol, a beta-blocking drug with vasodilating activity. Am J Cardiol 1986;58:916-21.
11. Hughes LO, Rose EL, Lahiri A, Raftery EB. Comparison of nicorandil and atenolol in stable angina pectoris. Am J Cardiol 1990;66:679-82.
12. Gould KL. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilatation. I. Physiologic basis and experimental validation. Am J Cardiol 1978;41:267-78.
13. Hickman M, Jeetley P, Sabharwal NK, et al. Extent of reversible myocardial perfusion abnormality determines the degree of post-ischaemic stunning [abstract]. J Nucl Cardiol 2003;10:S39.
14. Attenhofer CH, Pellikka PA, Oh JK, et al. Comparison of ischemic response during exercise and dobutamine echocardiography in patients with left main coronary artery disease. J Am Coll Cardiol 1996;27:1171-7.
15. Sharir T, Germano G, Kang X, et al. Prediction of myocardial infarction versus cardiac death by gated myocardial perfusion SPECT: risk stratification by the amount of stress-induced ischemia and the poststress ejection fraction. J Nucl Med 2001;42:831-7.
16. Hachamovitch R, Berman DS, Kiat H, et al. Value of stress myocardial perfusion single photon emission computed tomography in patients with normal resting electrocardiograms: an evaluation of incremental prognostic value and cost-effectiveness [see comments]. Circulation 2002;105:823-9.
17. Wahl JM, Hakki AH, Iskandrian AS. Prognostic implications of normal exercise thallium 201 images. Arch Intern Med 1985;145: 253-6.
18. Stratmann HG, Williams GA, Wittry MD, Chaitman BR, Miller DD. Exercise technetium-99m sestamibi tomography for cardiac risk stratification of patients with stable chest pain. Circulation 1994;89:615-22.
19. Hachamovitch R, Berman DS, Kiat H, et al. Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 1996;93:905-14.
20. Soman P, Parsons A, Lahiri N, Lahiri A. The prognostic value of a normal Tc-99m sestamibi SPECT study in suspected coronary artery disease. J Nucl Cardiol 1999;6:252-6.
21. Hendel RC, Layden JJ, Leppo JA. Prognostic value of dipyridamole thallium scintigraphy for evaluation of ischemic heart disease. J Am Coll Cardiol 1990;15:109-16.
22. Stratmann HG, Tamesis BR, Younis LT, Wittry MD, Miller DD. Prognostic value of dipyridamole technetium-99m sestamibi myocardial tomography in patients with stable chest pain who are unable to exercise. Am J Cardiol 1994;73:647-52.
23. Hachamovitch R, Berman DS, Kiat H, et al. Incremental prognostic value of adenosine stress myocardial perfusion single-photon emission computed tomography and impact on subsequent management in patients with or suspected of having myocardial ischemia. Am J Cardiol 1997;80:426-33.
24. Heller GV, Herman SD, Travin MI, et al. Independent prognostic value of intravenous dipyridamole with technetium-99m sestamibi tomographic imaging in predicting cardiac events and cardiac-related hospital admissions. J Am Coll Cardiol 1995; 26:1202-8.
25. Lette J, Bertrand C, Gossard D, et al. Long-term risk stratification with dipyridamole imaging. Am Heart J 1995;129:880-6.
26. Gibbons RJ, Balady GJ, Timothy BJ, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). J Am Coll Cardiol 2002;40:1531-40.
27. Basu S, Senior R, Raftery EB, Lahiri A. The association between cardiac events and myocardial ischaemia following thrombolysis in acute myocardial infarction and the impact of carvedilol. Eur Heart J 1996;17(Suppl F):43-7.
28. Brown BG, Bolson E, Petersen RB, Pierce CD, Dodge HT. The mechanisms of nitroglycerin action: stenosis vasodilatation as a major component of the drug response. Cirćulation 1981;64:1089-97.
29. Senior R, Kaul S, Raval U, Lahiri A. Impact of revascularization and myocardial viability determined by nitrate enhanced Tc-99m sestamibi and T1-201 imaging on mortality and functional outcome in ischemic cardiomyopathy. J Nucl Cardiol 2002;9:454-62.